ALS Therapy Development Institute (ALS TDI)
United States of America (USA)
1 July 2018 - 30 June 2019
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for ALS Therapy Development Institute (ALS TDI) published between 1 July 2018 - 30 June 2019 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| AC | FC |
|---|---|
| 1 | 0.13 |
Outputs by subject (FC)
| Subject | AC | FC | |
|---|---|---|---|
| Life Sciences | 1 | 0.13 | |
Top articles by Altmetric score in current window
A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis
Science Translational Medicine
2018-12-05
1 July 2018 - 30 June 2019
International vs. domestic collaboration by FC
- 0% Domestic
- 100% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by FC (0 total)
- ALS Therapy Development Institute (ALS TDI), United States of America (USA)
- Domestic institution
Top 10 international collaborators by FC (4 total)
- ALS Therapy Development Institute (ALS TDI), United States of America (USA)
- Foreign institution
Note: Collaboration is determined by the fractional count (FC), which is listed in parentheses.
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
